SPARK study: Studying Pathways of Resistance in KRAS-driven Cancers
Brief Summary “Up to 250 patients from anywhere in the United States can remotely consent and participate to have plasma drawn locally...
top of page
Search
Posts Coming Soon
Explore other categories in this blog or check back later.
Revolution Medicines: RMC-6236 Pancreatic Cancer Update to Support Pivotal Phase 3 Trial
Rev Med reports out on the 46% of the pancreatic cancer patients who were enrolled in NCT05379985 (54% of patients are NSLC or other...
Hug from Brenda
'I'm a woman of faith. I know where I'm going' These words were a gift to me from Brenda giving me comfort. The love this beautiful ...
bottom of page